Multiple backbone N‐methylation and macrocyclization improve the proteolytic stability and oral availability of therapeutic peptides. Chemical synthesis of such peptides is challenging, in particular for the generation of peptide libraries for screening purposes. Enzymatic backbone N‐methylation and macrocyclization occur as part of both non‐ribosomal and ribosomal peptide biosynthesis, exemplified by the fungal natural products cyclosporin A and omphalotin A, respectively. Omphalotin A, a 9fold backbone N‐methylated dodecamer isolated from the agaricomycete Omphalotus olearius, can be produced in Pichia pastoris by coexpression of the ophMA and ophP genes coding for the peptide precursor protein harbouring an autocatalytic peptide α‐N‐methyltransferase domain, and a peptide macrocyclase, respectively. Since both OphMA and OphP were previously shown to be relatively promiscuous in terms of peptide substrates, we expressed mutant versions of ophMA, encoding OphMA variants with altered core peptide sequences, along with wildtype ophP and assessed the production of the respective peptide macrocycles by the platform by high‐performance liquid chromatography, coupled with tandem mass spectrometry (HPLC–MS/MS). Our results demonstrate the successful production of fifteen non‐natural omphalotin‐derived macrocycles, containing polar, aromatic and charged residues, and, thus, suggest that the system may be used as biotechnological platform to generate libraries of non‐natural multiply backbone N‐methylated peptide macrocycles.
Protein phosphorylation regulates nearly every cellular process, yet most of the hundreds of thousands of human phosphosites remain functionally uncharacterized. Rather than prioritising phosphosites by conservation or structural features, here we use the abundance of an interaction partner as a readout of whether a phosphosite affects that interaction. This idea exploits the fact that subunits of stable complexes are often degraded when unbound. Here, we apply a nested linear regression model to pan-cancer data from 1,006 tumours, while controlling for transcriptional and other covariates. We identified 6,160 associations between 3,038 phosphosites and the abundance of interacting proteins, including several known interaction-regulating sites. Mapping these onto AlphaFold-predicted complexes placed 239 sites at interaction interfaces, while another 402 were linked to compartment-specific localisation, indicating that phosphorylation can also tune interactions by relocating proteins between compartments. Affinity-purification mass spectrometry of NKAP and NUF2 phosphosite mutants experimentally supported some of these predictions. Together, this framework reveals a widespread coupling between phosphorylation and interaction-dependent protein abundance and provides a prioritized, structure-informed resource for characterizing the human phosphoproteome